%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-10-23T19:50:11+03:00
2013-10-23T19:50:11+03:00
2013-10-23T19:50:11+03:00
application/pdf
bs-0730R-PE
uuid:0eba7042-f2b9-479a-b91a-52918890291f
uuid:cf3c39e5-9b84-4c1a-850c-f0608c6cb4d2
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[34 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.726 574.5 -735.891 re
f
BT
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 21.2908 767.2422 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw 0 -1.5 TD
[(800.501.7654)-34( )1([DOMESTIC])]TJ
0 -1.5 TD
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
141.4664764 0 0 -79.6994171 438.3843994 810.412735 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2983 0 0 9.2983 21.2908 715.4376 Tm
[(bs)-67(-)-69(0730R)-12(-)-69(PE)]TJ
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 28.5965 668.9462 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -2.091 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Heat)-31( Shock)-19( Protein)-81( 27)-90( \(HSP27\))-86( is)-52( a)-20( 27)-90( kDa)-26( member)-82( of)-48( a)-20( family)-88( of)-48( proteins)-87( whose)-3( expression)-45( and function)-77( are)]TJ
0 -1.455 TD
[(stimulated)-62( by)-40( heat)-57( shock)-39( and other)-43( stress)-78( stimuli.)-14( A)-36( major)-86( function)-77( of)-48( these)-65( proteins)-87( is)-52( to)-32( serve)-8( as)-29( chaperones)]TJ
0 -1.455 TD
[(that)-67( bind)-16( to)-32( and stabilize)-30( the)-36( active)-63( conformation)-6( of)-48( other)-43( proteins.)-57( HSP27,)-4( along)-47( with)-46( other)-43( members)-91( of)-48( the)]TJ
0 -1.455 TD
[(small)-4( HSP)-35( group,)-39( possesses)-76( a)-20( C)-35(-)-1(terminal)-35( Alpha)-80(-)-1(crystalline)-59( homology)-57( domain.)-85( HSP27)-34( is)-52( localized)-79( to)-32( the)-36( cytoplasm)]TJ
T*
[(of)-48( unstressed)-65( cells)-18( but)-10( can)-1( redistribute)-83( to)-32( the)-36( nucleus)-28( in)-31( response)-42( to)-32( stress,)-48( where)-15( it)-73( may)-46( function)-77( to)-32( stabilize)]TJ
0 -1.455 TD
[(DNA)-55( and/or)-79( the)-37( nuclear)-56( membrane.)-60( Cytoplasmic)-14( HSP27)-34( exists)-69( in)-31( multiple)-47( complexes.)-78( One)-26( complex)-80( consists)-82( of)]TJ
0 -1.455 TD
[(HSP27,)-4( Akt)-23( \(PKB\),)-21( MAPKAP)-66(-)-1(kinase)-36( 2,)-60( and p38)-82( MAPK.)-5( The)-59( presence)-44( of)-48( HSP27)-34( in)-31( this)-69( complex)-80( is)-52( required)-62( for)-52( Akt)]TJ
0 -1.455 TD
[(activation)-37( by)-40( stress)-78( stimuli.)-14( Another)-66( complex)-80( consists)-82( of)-48( HSP27)-34( and the)-37( IKK)-87( complex.)-50( HSP27)-34( is)-52( also)-75( an)-8( actin)]TJ
0 -1.455 TD
[(capping)-22( protein)-79( that)-67( binds)-25( to)-32( the)-36( barbed)-21( \(growing\))-60( ends)-8( of)-48( actin)-75( filaments,)-56( thereby)-9( inhibiting)-61( filament)-77( extension.)]TJ
T*
[(Phosphorylation)-63( of)-48( HSP27)-34( on)-81( serine)-82( 82)-90( by)-40( MAPKAP)-66(-)-1(kinase)-36( 2)-90( leads)-85( to)-32( HSP27)-34( dissociation)-86( from)-30( the)-36( Akt/MAPKAP)-70(-)]TJ
0 -1.455 TD
[(kinase)-36( 2/p38)-63( complex)-80( and from)-30( actin)-75( filaments,)-56( and stimulates)-78( HSP27)-34( binding)-40( to)-32( the)-36( IKK)-87( complex.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
0 Tw -6.727 -2 Td
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Aqueous)-34( buffered)-15( solution)-14( containing)-88( 100ug/ml)-73( BSA,)-42( 50%)-22( glycerol)-56( and less)-80( than)-25( 0.09%)-82( sodium)-13( azide.)-56( Store)-44( at)-50( -)]TJ
T*
[(20\260C)-18( for)-52( 12)-90( months.)-54( Protect)-73( from)-30( light.)-67( [Product)-75( without)-66( BSA)-72( and/or)-79( sodium)-13( azide)-87( is)-52( available)-70( for)-52( special)-31( order.])]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-36( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-37( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-36( package.)]TJ
/TT1 1 Tf
0 Tw 54.182 35.636 Td
(Size:)Tj
/TT0 1 Tf
3 -0.091 Td
(100ul)Tj
/TT1 1 Tf
-3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 424.437 623.1191 Tm
(Human,Mouse,Rat,Dog,Pig,Bovine,)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 609.1717 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 591.5714 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.3058 0 0 7.3058 441.041 589.911 Tm
[(IF\(1:100)-3(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 434.3994 580.9448 cm
0 0 m
0 1.328 -1.992 1.328 -1.992 0 c
-1.992 -1.328 0 -1.328 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.3058 0 0 7.3058 441.041 579.2844 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)]TJ
T*
[(Optimal)-36( working)-62( dilutions)-48( must)-4( be)]TJ
0 -1.455 TD
[(determined)-86( by)-40( the)-36( end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.6416 0 0 6.6416 467.6075 515.5248 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.3058 0 0 7.3058 424.437 501.5775 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.6416 0 0 6.6416 503.4723 501.5775 Tm
(27kDa)Tj
0 scn
/TT1 1 Tf
7.3058 0 0 7.3058 424.437 487.6301 Tm
(Note:)Tj
/TT0 1 Tf
0.021 Tw 5.9775 0 0 5.9775 424.437 460.3994 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)]TJ
0 -1.333 TD
[(animal)-94( )1(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
564.5375671 0 0 -0.6641693 15.3132935 706.8034821 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 21.2908 81.8272 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 19.2983 691.5278 cm
0 0 m
0 1.771 -2.657 1.771 -2.657 0 c
-2.657 -1.771 0 -1.771 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2983 0 0 9.2983 28.5965 688.8711 Tm
[(Rabbit)-50( Anti)-28(-)-69(HSP27)-29( Polyclonal)-4( Antibody,)-47( PE)-14( conjugated)]TJ
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 25.2757263 395.3115692 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
0 Tw 10.6266 0 0 10.6266 25.2757 310.963 Tm
( )Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 153.4589691 395.3115692 cm
/Im3 Do
Q
BT
/TT0 1 Tf
10.6266 0 0 10.6266 153.459 310.963 Tm
( )Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 282.306366 395.3115692 cm
/Im4 Do
Q
BT
/TT0 1 Tf
10.6266 0 0 10.6266 282.3064 310.963 Tm
( )Tj
ET
q
/GS0 gs
99.6242828 0 0 -75.050293 25.2757263 307.6421967 cm
/Im5 Do
Q
BT
/TT0 1 Tf
10.6266 0 0 10.6266 25.2757 223.2936 Tm
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-24.188 -2.25 Td
( )Tj
12.063 0 Td
( )Tj
12.125 0 Td
( )Tj
-0.04 Tw 7.3058 0 0 7.3058 26.604 167.504 Tm
[(For)-30( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.6416 0 0 6.6416 180.6896 167.504 Tm
(HERE)Tj
/CS0 cs 0 scn
7.3058 0 0 7.3058 197.2936 167.504 Tm
(.)Tj
ET
q
/GS0 gs
0.6641693 0 0 -597.7456512 410.4896088 706.1392975 cm
/Im6 Do
Q
q
/GS0 gs
5.9774628 0 0 -40.5138702 569.888443 120.3485565 cm
/Im7 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
($p~Y&k9)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L